StepStone reports 6.6% stake in OnKure (Class A)
OnKure Therapeutics ownership filing: StepStone entities report shared beneficial ownership of 2,660,612 shares of Class A Common Stock, representing 6.6% of the class.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
OnKure Therapeutics ownership filing: StepStone entities report shared beneficial ownership of 2,660,612 shares of Class A Common Stock, representing 6.6% of the class. The filing cites 40,395,478 shares outstanding as of April 1, 2026. The report attributes shared voting and dispositive power to StepStone-related partnerships and managers.
Key Figures
Key Terms
Schedule 13G regulatory
Beneficial ownership financial
CUSIP market
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does StepStone report in OnKure (OKUR)?
Which StepStone entities are named in the Schedule 13G for OKUR?
What voting and dispositive powers are reported by StepStone?
Who signed the Schedule 13G on behalf of StepStone?
AI-generated analysis. How Rhea-AI works. Not financial advice.